Transplant Diagnostics Market Scope And Analysis

Report Code : TIPRE00003076
Category : Life Sciences

No. of Pages : 150

Buy Now

Transplant Diagnostics Market Analysis and Scope (2023 to 2031)

Buy Now

Transplant Diagnostics Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 1,070.65 Million
Market Size by 2031	US$ 1,967.06 Million
Global CAGR (2023 - 2031)	7.90%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Product and Services Instruments Reagents & Consumables Software & Services By Type Solid Organ Transplantation Soft Tissue Transplantation Stem Cell Transplantation By Technology Molecular Assays and Non-Molecular Assays By Application Diagnostic Applications and Research Applications
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Bio Rad Laboratories Hologic Illumina Inc Thermo Fisher Scientific QIAGEN NV Omixon Inc Abbott

Transplant Diagnostics Market News and Recent Developments

The Transplant Diagnostics Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the Transplant Diagnostics market:

Thermo Fisher Scientific added two new products to its transplant diagnostics portfolio during the American Society for Histocompatibility and Immunogenetics (ASHI) annual conference. (Source: Thermo Fisher Scientific, Press Release/Company Website/Newsletter, October 2023)
Immucor, Inc., a company focused on transfusion and transplantation diagnostics, announced two additions to its transplant diagnostics portfolio, demonstrating its ongoing commitment to new advancements in the field of histocompatibility. (Source: Immucor, Press Release/Company Website/Newsletter, March 2022)
Biocartis and Ophiomics entered into a collaboration to focus on the commercialization of HepatoPredict, a prognostic gene expression signature test to identify which patients will benefit from liver transplantation (Source: Biocartis, Press Release/Company Website/Newsletter, March 2022)

Transplant Diagnostics Market Report Coverage and Deliverables

The “Transplant Diagnostics Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles